British pharmaceutical giant ... with BioKangtai will see the company open its first vaccine manufacturing facility in China. AstraZeneca's Beijing research hub will be the second of its kind ...

AstraZeneca said on Friday it will spend $2.5 billion on a research and development hub in Beijing, as the drugmaker scrambles to revive business in its second-biggest market after scandals including ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

Popular Western medicines for diseases including cancer and diabetes have been caught in the escalating U.S.-China trade war, ...

The logo of US pharmaceutical company Pfizer at the 7th China International Import Expo in Shanghai, on Nov 7, 2024. [Photo/VCG] BEIJING - US pharmaceutical giant Pfizer's new research and development ...

President Trump said Tuesday his administration soon would announce “major” tariffs on pharmaceuticals, adding to the tariffs ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

These leaders praised Beijing's development and pledged increased investment. AstraZeneca, the global pharmaceutical company, signed a $2.5 billion agreement last Friday to invest in Beijing over ...

Trump said he would announce pharmaceutical tariffs, as he increased tariffs on China to 125% and paused tariffs for 75 ...

AstraZeneca on Friday said that it will invest $2.5 billion in a research and development center in Chinese capital Beijing, months after the British pharmaceutical giant faced local regulators ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...